The establishment of an ELISA for measuring GITR and GITRL and its clinical application

SUN Lishan,FAN Lieying,ZHANG Hui,ZHENG Huiya,ZONG Ming,ZHU Haibo
DOI: https://doi.org/10.3969/j.issn.1673-8640.2009.12.013
IF: 1.865
2009-01-01
Laboratory Medicine
Abstract:Objective To establish an enzyme-linked immunosorbent assay(ELISA) for measuring glucocorticoid-induced tumor necrosis factor receptor(GITR)and glucocorticoid-induced tumor necrosis factor receptor ligand(GITRL),and explore the clinical application of the measurement of GITR and GITRL in the diagnosis and monitoring rheumatoid arthritis(RA) and tumor diseases.Methods With mouse monocolonal anti-human GITR and GITRL antibody as coating antibody and biotin-streptavidin-horseradish peroxidase(SA-HRP) as detecting system,a double antibodies sandwich ELISA was established for measuring GITR and GITRL.The serum levels of GITR and GITRL from 105 patients with RA,54 patients with tumor and 100 healthy subjects were measured and the relationship of GITR and GITRL with RA and tumor diseases was analyzed.Results The correlation coefficient(r2) was 0.94 for GITR assay and 0.90 for GITRL assay.The levels of GITR and GITRL in patients with RA were higher than those in healthy subjects(P<0.001).The levels of GITR in patients with tumor were higher than those in healthy subjects(P<0.001),and there was no significant difference for GITRL levels(P>0.05).Conclusions An ELISA for measuring the GITR and GITRL in serum is successfully established.GITR and GITRL in serum may be new assistant diagnostic or monitoring parameters for RA.
What problem does this paper attempt to address?